|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
|
|---|---|---|---|---|---|
| Revenues | |||||
| Premiums | |||||
| Net investment income | |||||
| Net realized and unrealized investment gains (losses): | |||||
| Net realized losses from sales and other | |||||
| Net change in fair value of equity securities | |||||
| Net change in fair value of equity securities and other | |||||
| Impairments on investments: | |||||
| Credit-related impairments | |||||
| Losses on intent to sell securities | |||||
| Recoveries (impairments) on investments | |||||
| Total impairments on investments | |||||
| Total net realized and unrealized investment losses | |||||
| Fees and other income | |||||
| Total revenues | |||||
| Losses and expenses | |||||
| Losses and loss adjustment expenses | |||||
| Amortization of deferred acquisition costs | |||||
| Interest expense | |||||
| Other operating expenses | |||||
| Total losses and expenses | |||||
| Income from continuing operations before income taxes | |||||
| Income tax expense (benefit): | |||||
| Current | |||||
| Deferred | |||||
| Total income tax expense | |||||
| Income from continuing operations | |||||
| Discontinued operations (net of taxes): | |||||
| Income from discontinued life businesses, net of taxes | |||||
| Chaucer | |||||
| Life | |||||
| Net income | |||||
| Earnings per common share: | |||||
| Basic: | |||||
| Income from continuing operations | |||||
| Income from discontinued businesses, net of taxes | |||||
| Chaucer | |||||
| Life | |||||
| Net income per share | |||||
| Weighted average shares outstanding | |||||
| Diluted: | |||||
| Income from continuing operations | |||||
| Income from discontinued businesses, net of taxes | |||||
| Chaucer | |||||
| Life | |||||
| Net income per share |
Loading...